Biomea Fusion Company

Biomea Fusion is a precision oncology company developing novel small molecules that target aggressive forms of cancer.

Estimated Revenue: $10M to $50M
Last Funding Date: 2021-01-06
Investors Number: 8.0
Industry: Early Drug Development
Funding Status: IPO
Technology: Biotechnology, Life Science, Therapeutics
Employee Number: 11-50
Headquarters: Redwood City, California, United States
Last Funding Type: Series A
Total Funding: 56000000.0
Founded Date: 2017-01-01